Who owns CAMP4 THERAPEUTICS CORP?
- Ticker: CAMP
- CUSIP Number: 13463j101
Tip: Access positions for across all investors
Analyze quarterly positions in Camp4 Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Camp4 Therapeutics Corp stock
Who bought or sold CAMP4 THERAPEUTICS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 6.3M | $28M | 36% | Mar 2026 |
|
| 5AM Venture Management | 5.9M | $26M | 0% | Mar 2026 |
|
| FMR | 4.9M | $30M | 63% | Dec 2025 |
|
| Vivo Capital | 4.2M | $19M | 0% | Mar 2026 |
|
| Balyasny Asset Management | 2.6M | $12M | 8% | Mar 2026 |
|
| Enavate Sciences GP | 2.2M | $9.7M | -28% | Mar 2026 |
|
| Adage Capital Partners GP | 2.2M | $13M | 11% | Dec 2025 |
|
| AH Capital Management | 2.1M | $9.4M | 0% | Mar 2026 |
|
| Trails Edge Capital Partners | 1.9M | $8.6M | 100% | Mar 2026 |
|
| Vanguard Group | 1.7M | $10M | 434% | Dec 2025 |
|
| Vanguard Capital Management | 1.5M | $6.8M | 100% | Mar 2026 |
|
| HarbourVest Partners | 1.3M | $7.8M | 0% | Dec 2025 |
|
| BlackRock | 456k | $2.0M | 17% | Mar 2026 |
|
| Geode Capital Management | 383k | $1.7M | 14% | Mar 2026 |
|
| SummitTX Capital | 340k | $1.5M | 100% | Mar 2026 |
|
| Stonepine Capital Management | 229k | $1.4M | 100% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 195k | $860k | 100% | Mar 2026 |
|
| Two Sigma Investments | 109k | $480k | 15% | Mar 2026 |
|
| 683 Capital Management | 108k | $476k | -15% | Mar 2026 |
|
| Millennium Management | 86k | $379k | 751% | Mar 2026 |
|
| Victory Capital Management | 83k | $508k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 78k | $346k | 316% | Mar 2026 |
|
| Northern Trust | 75k | $457k | 410% | Dec 2025 |
|
| Barclays | 74k | $451k | 105044% | Dec 2025 |
|
| Hudson Bay Capital Management | 49k | $214k | 100% | Mar 2026 |
|
| State Street Corporation | 40k | $243k | 53% | Dec 2025 |
|
| Bank of America Corporation | 31k | $138k | 100% | Mar 2026 |
|
| Hrt Financial | 31k | $135k | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 25k | $153k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 19k | $83k | 0% | Mar 2026 |
|
| Point72 Asset Management | 17k | $76k | 100% | Mar 2026 |
|
| China Universal Asset Management | 16k | $71k | 60% | Mar 2026 |
|
| Brevan Howard Capital Management | 15k | $64k | 100% | Mar 2026 |
|
| Diametric Capital | 14k | $64k | 100% | Mar 2026 |
|
| Scientech Research | 13k | $56k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 12k | $51k | 100% | Mar 2026 |
|
| Citigroup | 9.9k | $44k | 100% | Mar 2026 |
|
| Morgan Stanley | 9.5k | $38k | -4% | Mar 2026 |
|
| UBS Group | 9.1k | $40k | 77% | Mar 2026 |
|
| Tower Research Capital | 406.00 | $2.5k | -93% | Dec 2025 |
|
| Royal Bank of Canada | 236.00 | $1.0k | -75% | Mar 2026 |
|
| Caitong International Asset Management | 74.00 | $325.999600 | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 36.00 | $159.001200 | 9% | Mar 2026 |
|
| SBI Securities | 10.00 | $44.000000 | 0% | Mar 2026 |
|
Who sold out of Camp4 Therapeutics Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Silverarc Capital Management | Sep 2025 | 654k | $2.0M |
| EcoR1 Capital | Dec 2025 | 325k | $2.0M |
| Alyeska Investment Group | Dec 2025 | 200k | $1.2M |
| ExodusPoint Capital Management | Dec 2025 | 35k | $213k |
| Jane Street | Dec 2025 | 26k | $157k |
| OMERS Administration Corporation | Dec 2025 | 19k | $115k |
| Mariner Wealth Advisors | Dec 2025 | 15k | $94k |
| Leucadia National Corporation | Dec 2025 | 11k | $70k |